scispace - formally typeset
J

Jamie Heimburg-Molinaro

Researcher at Beth Israel Deaconess Medical Center

Publications -  67
Citations -  2604

Jamie Heimburg-Molinaro is an academic researcher from Beth Israel Deaconess Medical Center. The author has contributed to research in topics: Glycan & Antigen. The author has an hindex of 25, co-authored 59 publications receiving 2132 citations. Previous affiliations of Jamie Heimburg-Molinaro include University at Buffalo & State University of New York System.

Papers
More filters
Journal ArticleDOI

Innate immune lectins kill bacteria expressing blood group antigen

TL;DR: Two innate immune lectins, galectin-4 (Gal-4) and Gal-8, which are expressed in the intestinal tract, recognize and kill human blood group antigen–expressing Escherichia coli while failing to alter the viability of other E. coli strains or other Gram-negative or Gram-positive organisms both in vitro and in vivo.
Journal ArticleDOI

Cancer Vaccines and Carbohydrate Epitopes

TL;DR: The role of each of the above mentioned carbohydrate antIGens in cancer growth and metastasis and vaccine attempts using these antigens will be described.
Journal ArticleDOI

Microbial glycan microarrays define key features of host-microbial interactions

TL;DR: It is discovered that several innate immune galectins show specific recognition of microbes that express self-like antigens, leading to direct killing of a broad range of Gram-negative and Gram-positive microbes.
Book ChapterDOI

Simple sugars to complex disease--mucin-type O-glycans in cancer.

TL;DR: Mucin-type O-glycan biosynthesis, altered mucin- type O- glycans in primary tumors, including mechanisms for structural changes and contributions to the tumor phenotype, and clinical approaches to detect and target altered O- Glycans for cancer treatment and management are described.
Journal ArticleDOI

Shotgun glycomics: a microarray strategy for functional glycomics

TL;DR: This work focuses on glycosphingolipids, a class of glycoconjugates that is challenging to study, recognized by toxins, antibodies and GBPs, and derivatized GSLs extracted from cells with a heterobifunctional fluorescent tag suitable for covalent immobilization.